Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10

Cost–consequence analysis of fluticasone furoate/vilanterol 92/22 mcg for the management of COPD in the Spanish NHS

Total article views   HTML views PDF downloads Totals
7,425 Dovepress* 7,010+ 1,067 8,077
PubMed Central* 415 115 530
Totals 7,425 1,182 8,607
*Since 5 September 2018

View citations on PubMed Central and Google Scholar